GMM is also focussing on non glass lined businesses, therefore there margins and revenue not picking up due to slowdown in chemical & pharma (though looks like improving gradually) and capex in non glass lined.
The guidance itself is very conservative which means they don’t want to create unnecessary hype.
What drives me towards the company is the management (acquiring the parent company) and expanding overseas. Sooner rather later the glass lined business will perform. The OPM is around 14% since 4 FY’s and not so volatile since 8 quarters, that proves management’s calibre.
Invested and tracking closely.
| Subscribe To Our Free Newsletter |
